Li et al. revealed that the downregulation of BCL-2 by miR-34a restores the apoptotic pathways in Osteosarcoma cells, resulting in enhanced cell death, particularly when paired with chemotherapeutic drugs like cisplatin [60]. This evidence concerns the gene BCL2 and osteosarcoma.